Clonal Isolation of Muscle-Derived Cells Capable of Enhancing Muscle Regeneration and Bone Healing

Several recent studies suggest the isolation of stem cells in skeletal muscle, but the functional properties of these muscle-derived stem cells is still unclear. In the present study, we report the purification of muscle-derived stem cells from the mdx mouse, an animal model for Duchenne muscular dystrophy. We show that enrichment of desmin+ cells using the preplate technique from mouse primary muscle cell culture also enriches a cell population expressing CD34 and Bcl-2. The CD34+ cells and Bcl-2+ cells were found to reside within the basal lamina, where satellite cells are normally found. Clonal isolation and characterization from this CD34+Bcl-2+ enriched population yielded a putative muscle-derived stem cell, mc13, that is capable of differentiating into both myogenic and osteogenic lineage in vitro and in vivo. The mc13 cells are c-kit and CD45 negative and express: desmin, c-met and MNF, three markers expressed in early myogenic progenitors; Flk-1, a mouse homologue of KDR recently identified in humans as a key marker in hematopoietic cells with stem cell-like characteristics; and Sca-1, a marker for both skeletal muscle and hematopoietic stem cells. Intramuscular, and more importantly, intravenous injection of mc13 cells result in muscle regeneration and partial restoration of dystrophin in mdx mice. Transplantation of mc13 cells engineered to secrete osteogenic protein differentiate in osteogenic lineage and accelerate healing of a skull defect in SCID mice. Taken together, these results suggest the isolation of a population of muscle-derived stem cells capable of improving both muscle regeneration and bone healing.

[1]  J. Lee,et al.  Osteoprogenitor cells within skeletal muscle , 2000, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[2]  J. Lee,et al.  Ex Vivo Gene Therapy to Produce Bone Using Different Cell Types , 2000, Clinical orthopaedics and related research.

[3]  J. Huard,et al.  The Influence of Muscle Fiber Type in Myoblast-Mediated Gene Transfer to Skeletal Muscles , 2000, Cell transplantation.

[4]  J. Huard,et al.  Matching host muscle and donor myoblasts for myosin heavy chain improves myoblast transfer therapy , 2000, Gene Therapy.

[5]  M. Rudnicki,et al.  A new look at the origin, function, and "stem-cell" status of muscle satellite cells. , 2000, Developmental biology.

[6]  M. Goodell,et al.  Hematopoietic potential of stem cells isolated from murine skeletal muscle. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[7]  L. De Angelis,et al.  Skeletal Myogenic Progenitors Originating from Embryonic Dorsal Aorta Coexpress Endothelial and Myogenic Markers and Contribute to Postnatal Muscle Growth and Regeneration , 1999, The Journal of cell biology.

[8]  M. Ogawa,et al.  Reversible expression of CD34 by murine hematopoietic stem cells. , 1999, Blood.

[9]  M. Goodell.  CD34+ or CD34−: Does it Really Matter? , 1999 .

[10]  R. Mulligan,et al.  Dystrophin expression in the mdx mouse restored by stem cell transplantation , 1999, Nature.

[11]  C. Peschle,et al.  KDR receptor: a key marker defining hematopoietic stem cells. , 1999, Science.

[12]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[13]  T. Partridge,et al.  Dynamics of Myoblast Transplantation Reveal a Discrete Minority of Precursors with Stem Cell–like Properties as the Myogenic Source , 1999, The Journal of cell biology.

[14]  Erwin Hauser,et al.  Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice , 1999, Anatomy and Embryology.

[15]  K. Satomura,et al.  Repair of craniotomy defects using bone marrow stromal cells. , 1998, Transplantation.

[16]  Johnny Huard,et al.  Development of Approaches to Improve Cell Survival in Myoblast Transfer Therapy , 1998, The Journal of cell biology.

[17]  J. Dominov,et al.  Bcl-2 Expression Identifies an Early Stage of Myogenesis and Promotes Clonal Expansion of Muscle Cells , 1998, The Journal of cell biology.

[18]  G. Dickson,et al.  Effective restoration of dystrophin‐associated proteins in vivo by adenovirus‐mediated transfer of truncated dystrophin cDNAs , 1998, FEBS letters.

[19]  G Cossu,et al.  Muscle regeneration by bone marrow-derived myogenic progenitors. , 1998, Science.

[20]  B. Wold,et al.  Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. , 1997, Developmental biology.

[21]  R. Bassel-Duby,et al.  Transient expression of a winged-helix protein, MNF-beta, during myogenesis , 1997, Molecular and cellular biology.

[22]  L. Kunkel,et al.  The fate of individual myoblasts after transplantation into muscles of DMD patients , 1997, Nature Medicine.

[23]  J. Tremblay,et al.  Control of inflammatory damage by anti-LFA-1: increase success of myoblast transplantation. , 1997, Cell transplantation.

[24]  M. Grounds,et al.  Rapid death of injected myoblasts in myoblast transfer therapy , 1996, Muscle & nerve.

[25]  C. Bader,et al.  Identification of self-renewing myoblasts in the progeny of single human muscle satellite cells. , 1996, Differentiation; research in biological diversity.

[26]  R. Roy,et al.  Successful histocompatible myoblast transplantation in dystrophin- deficient mdx mouse despite the production of antibodies against dystrophin , 1995, The Journal of cell biology.

[27]  H. E. Young,et al.  A population of cells resident within embryonic and newborn rat skeletal muscle is capable of differentiating into multiple mesodermal phenotypes , 1995, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[28]  R. R. Rice,et al.  Myoblast transfer in the treatment of Duchenne's muscular dystrophy. , 1995, The New England journal of medicine.

[29]  E. Füchtbauer,et al.  M-twist expression inhibits mouse embryonic stem cell-derived myogenic differentiation in vitro. , 1995, Experimental cell research.

[30]  J. Smith,et al.  Mesenchymal stem cells reside within the connective tissues of many organs , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[31]  V. Rosen,et al.  Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage [published erratum appears in J Cell Biol 1995 Feb;128(4):following 713] , 1994, The Journal of cell biology.

[32]  R. Roy,et al.  Very efficient myoblast allotransplantation in mice under FK506 immunosuppression , 1994, Muscle & nerve.

[33]  G. Acsadi,et al.  Gene transfer into skeletal muscles by isogenic myoblasts. , 1994, Human gene therapy.

[34]  H. Blau,et al.  Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy , 1994, The Journal of cell biology.

[35]  A. Irintchev,et al.  Expression pattern of M‐cadherin in normal, denervated, and regenerating mouse muscles , 1994, Developmental dynamics : an official publication of the American Association of Anatomists.

[36]  J. Huard,et al.  Human myoblast transplantation in immunodeficient and immunosuppressed mice: Evidence of rejection , 1994, Muscle & nerve.

[37]  J. Tremblay,et al.  High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice. , 1994, The Journal of clinical investigation.

[38]  T. Partridge,et al.  Long-term persistence and migration of myogenic cells injected into pre-irradiated muscles of mdx mice , 1993, Journal of the Neurological Sciences.

[39]  J. Bouchard,et al.  Results of a Triple Blind Clinical Study of Myoblast Transplantations without Immunosuppressive Treatment in Young Boys with Duchenne Muscular Dystrophy , 1993, Cell transplantation.

[40]  C. Richards,et al.  Human myoblast transplantation between immunohistocompatible donors and recipients produces immune reactions. , 1992, Transplantation proceedings.

[41]  H. Blau,et al.  Anorectal incontinence in myotonic dystrophy: a myopathic involvement of pelvic floor muscles. , 1992 .

[42]  J. Bouchard,et al.  Human myoblast transplantation: Preliminary results of 4 cases , 1992, Muscle & nerve.

[43]  H. Blau,et al.  Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation , 1992, Nature.

[44]  B. Roy,et al.  Human myoblast transplantation: A simple assay for tumorigenicity , 1991, Neuromuscular Disorders.

[45]  P. Simmons,et al.  CD34 expression by stromal precursors in normal human adult bone marrow. , 1991, Blood.

[46]  J. Ervasti,et al.  Membrane organization of the dystrophin-glycoprotein complex , 1991, Cell.

[47]  T. Partridge.  Invited review: Myoblast transfer: A possible therapy for inherited myopathies? , 1991, Muscle & nerve.

[48]  E. Hoffman,et al.  Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse , 1990, The Journal of cell biology.

[49]  M. Greaves,et al.  Expression of the CD34 gene in vascular endothelial cells. , 1990, Blood.

[50]  Y. Pouliot,et al.  Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation. , 1989, The American journal of pathology.

[51]  L. Kunkel,et al.  Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts , 1989, Nature.

[52]  D. Watt,et al.  Partial correction of an inherited biochemical defect of skeletal muscle by grafts of normal muscle precursor cells , 1988, Journal of the Neurological Sciences.

[53]  S. Dimauro,et al.  Duchenne muscular dystrophy: Deficiency of dystrophin at the muscle cell surface , 1988, Cell.

[54]  Hideo Sugita,et al.  Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide , 1988, Nature.

[55]  Simon C Watkins,et al.  Immunoelectron microscopic localization of dystrophin in myofibres , 1988, Nature.

[56]  R. Hodges,et al.  The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle , 1988, Nature.

[57]  I. Bernstein,et al.  Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors , 1986 .

[58]  M. Fackler,et al.  Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. , 1984, Journal of immunology.

[59]  U. Francke,et al.  Identification of the mouse chromosomes by quinacrine mustard staining. , 1971, Cytogenetics.

[60]  N. Takahashi,et al.  Bone Morphogenetic Protein-2 Converts the Differentiation Pathway of C2C12 Myoblasts into the Osteoblast Lineage , 2002 .

[61]  J. Miller,et al.  Seeking muscle stem cells. , 1999, Current topics in developmental biology.

[62]  R. Worton,et al.  Myoblast transfer in DMD: problems in the interpretation of efficiency. , 1992, Muscle & nerve.

[63]  Eric P. Hoffman,et al.  Dystrophin: The protein product of the duchenne muscular dystrophy locus , 1987, Cell.

[64]  R. Andrews,et al.  Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. , 1986, Blood.

[65]  K Yamada,et al.  [Chromosome analysis]. , 1979, Nihon rinsho. Japanese journal of clinical medicine.